Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2008-10-10
2011-12-13
Russel, Jeffrey E (Department: 1654)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C514S002800, C514S021100, C530S317000
Reexamination Certificate
active
08076285
ABSTRACT:
The invention relates to lysobactin amides and methods for their preparation, as well as their use for manufacturing medicaments for the treatment and/or prophylaxis of diseases, in particular bacterial infectious diseases.
REFERENCES:
patent: 4754018 (1988-06-01), Tymiak et al.
patent: 6380156 (2002-04-01), Rinehart et al.
patent: 7056942 (2006-06-01), Hildesheim et al.
patent: 7368424 (2008-05-01), Von Nussbaum et al.
patent: 7531507 (2009-05-01), Von Nussbaum et al.
patent: 2005/0075281 (2005-04-01), Von Nussbaum et al.
patent: 2005/0272646 (2005-12-01), Koteva et al.
patent: 2006/0264358 (2006-11-01), Von Nussbaum et al.
patent: 2008/0051424 (2008-02-01), Von Nussbaum et al.
patent: 2008/0058251 (2008-03-01), Von Nussbaum et al.
patent: 2008/0058253 (2008-03-01), Von Nussbaum et al.
patent: 2008/0070884 (2008-03-01), Von Nussbaum et al.
patent: 2009/0105119 (2009-04-01), Von Nussbaum et al.
patent: 10 2004 053410 (2006-05-01), None
patent: 0 196 042 (1986-10-01), None
patent: 01132600 (1989-05-01), None
patent: WO-01/05814 (2001-01-01), None
patent: WO-2004/099239 (2004-11-01), None
patent: WO-2006/048156 (2006-05-01), None
A Guide to IUPAC Nomenclature of Organic Compounds (Recommendations 1993) 1993, Blackwell Scientific Publications.
Baquero, J. Antimicrob. Chemother. (1997) 39(Suppl. A):1-6.
Barret et al., Tetrahedron Letters (2001) 42(4):703-705.
Bonner et al., J. Antibiot. (1988) 41:1745-1751.
Bull et al., J. Chem. Soc. Perkin Trans. (2001) 1:3281-3287.
Cardillo et al., Synlett (1999) 1727-1730.
Cohen et al., J. Am. Chem. Soc. (2004) 124:2534-2543.
Echner et al., Liebigs Ann. Chem. (1988) 1095-1098.
Goldrick, Am. J. Nurs. (2002) 102:17.
Green, Expert Opin. Ther. Targets (2002) 6:1-19.
International Search Report and Written Opinion for PCT/EP2007/003303, dated Jul. 19, 2007, 16 pages.
Jetten et al., Tetrahedron Lett. (1991) 32:6025-6028.
Jiang et al., J. Am. Chem. Soc. (2003) 125:1877-1887.
Johnson et al., J. Hosp. Infect. (2001) 49(Suppl. A):3-11.
Kalvin et al., J. Org. Chem. (1985) 50(13):2259-2263.
Mattingly et al., J. Org. Chem. (1983) 48:3556-3559.
McGregor, J. Am. Chem. Soc. (1957) 79:6180.
Merget et al., J. Organomet. Chem. (2001) 628:183-194.
Murakami et al., Tetrahedron (2000) 56(46):9121-9128.
Nomenclature and symbolism for amino acids and peptides, Recommendations 1983, IUPAC-IUB Joint Commission on Biochemical Nomenclature, UK, Biochemical Journal (1984) 219:345-373.
Norman et al., Journal of Organic Chemistry (1998) 63(15):5288-5294.
Oliyai et al., Pharm. Res. (1995) 12(3):323-328.
O'Sullivan et al., J. Antibiot. (1988) 41:1740-1744.
Rama et al., Tetrahedron Lett. (1991) 32:4393-4396.
Rane et al., Tetrahedron Lett. (1993) 34(20):3201-3204.
Shemyakin et al., Esperienta (1966) 22(8):535-536.
Shoji et al., J. Antibiot. (1988) 41:713-718.
Schumacher et al., Journal of Pharmaceutical Sciences (2004) 93:816-830.
Tymiak et al., J. Org. Chem. (1989) 54:1149-1157.
Ulhaq et al., Bioorg. Med. Chem. (1999) 7(9):1787-1796.
Alker et al., Tetrahedron (1998) 54:6089-6098.
Anderson and McGregor, J Am Chem Soc (1957) 79:6180-6183.
Bacterial Urinary Tract Infections from the Merck Manual, 8 pages (2007).
Belokon et al., Tetrahedron: Asymmetry (2001) 12:481-485.
Blackburn et al., Drug Metabolism and Disposition (1993) 21(4):573-579.
Cellulitis from the Merck Manual, 3 pages, (2007).
Cystic Fibrosis from the Merck Manual, 7 pages, (2007).
Dikler et al., J Mass Spectrometry (1997) 32:1337-1349.
English Translation of the International Preliminary Report on Patentability for PCT/EP2005/010856, issued on Apr. 24, 2007, 10 pages.
Harada et al., J of Chrom (2001) 932:75-81.
Hingley, retrieved from http://www.fda.gov/FDAC/features/1998/398—alz.htm on Jan. 7, 2009, 6 pages.
International Search Report for PCT/EP2005/010857, mailed on Mar. 27, 2006, 4 pages.
International Search Report for PCT/EP2005/011451, mailed on Feb. 27, 2006, 4 pages.
International Search Report for PCT/EP2007/000645, mailed on May 7, 2007, 4 pages.
International Search Report and Written Opinion for PCT/EP2007/003313, dated Jul. 20, 2007, 10 pages.
IUPAC, Nomenclature and Symbolism for Amino Acids and Peptides, Names and Symbols for Derivatives of Named Peptides, Section 3AA-22 (Recommendations 1983-1992).
Kato et al., J Antibiot (1988) 41:719-725.
Lee et al., Tetrahedron (2001) 57:2139-2145.
Maki et al., Antimicrob Agents and Chemotherapy (2001) 45(6):1823-1827.
Merino et al., Tetrahedron: Asymmetry (1998) 9:629-646.
Neises et al., Org Synth (1985) 63:183-187.
Palomo et al., Tetrahedron Lett (2001) 42:8955-8957.
Panico et al., eds., A Guide to IUPAC Nomenclature of Organic Compounds, Blackwell Science LTD., 1993, pp. 1-190 (Recommendations 1993).
Rao et al., Tetrahedron Lett (1991) 32:4393-4396.
Seebach et al., Hely Chim Acta (1996) 79:913-941.
Tenover, Am J Infect Control (2006) 34:S3-S10.
Thornber, Chem Soc Rev (1979) 8(4):563-580.
Translation of the International Preliminary Report on Patentability for PCT/EP2005/011451, mailed Jul. 12, 2007, 8 pages.
Translation of the International Preliminary Report on Patentability for PCT/EP2005/010857, Apr. 24, 2007, 11 pages.
Translation of the International Preliminary Report on Patentability for PCT/EP2005/010858, issued Apr. 24,2007, 5 pages.
Translation of the International Preliminary Report on Patentability for PCT/EP2007/000645, issued Sep. 9, 2008, 9 pages.
Van Hof et al., Biol Chem (2001) 382:597-619.
Vippagunta et al., Adv Drug Delivery Rev (2001) 48:3-26.
U.S. Appl. No. 10/840,749, filed on May 6, 2004 [Von Nussbaum et al.].
Preliminary Amendment for U.S. Appl. No. 10/840,749, filed Dec. 17, 2004, 15 pages.
Restriction Requirement for U.S. Appl. No. 10/840,749, mailed Dec. 5, 2005, 7 pages.
Request for Extension of Time and Response to Restriction Requirement for U.S. Appl. No. 10/840,749, filed May 8, 2005, 2 pages.
Non-Final Office Action for U.S. Appl. No. 10/840,749, mailed on Aug. 8, 2006, 7 pages.
Amendment in Response to Non-Final Office Action for U.S. Appl. No. 10/840,749, filed on Nov. 8, 2006, 14 pages.
Non-Final Office Action for U.S. Appl. No. 10/840,749, mailed on Feb. 22, 2007, 11 pages.
Terminal Disclaimer for U.S. Appl. No. 10/840,749, filed on Jun. 22, 2007, 1 page.
Amendment in Response to Non-Final Office Action for U.S. Appl. No. 10/840,749, filed on Jun. 22, 2007, 16 pages.
Supplemental Amendment in Response to Non-Final Office Action for U.S. Appl. No. 10/840,749, filed on Nov. 20, 2007, 15 pages.
Notice of Allowance for U.S. Appl. No. 10/840,749, mailed on Dec. 3, 2007, 6 pages.
U.S. Appl. No. 11/267,063, filed on Nov. 4, 2005 [Von Nussbaum et al.].
Preliminary Amendment for U.S. Appl. No. 11/267,063, filed on Jul. 13, 2006, 7 pages.
Restriction Requirement for U.S. Appl. No. 11/267,063, mailed on Apr. 12, 2007, 8 pages.
Amendment in Response to Non-Final Office Action for U.S. Appl. No. 11/267,063, filed on Jul. 11, 2007, 8 pages.
Non-Final Office Action for U.S. Appl. No. 11/267,063, mailed on Aug. 17, 2007, 18 pages.
Amendment in Response to Non-Final Office Action for U.S. Appl. No. 11/267,063, filed Jan. 15, 2008, 9 pages.
Non-Final Office Action for U.S. Appl. No. 11/267,063, mailed on Apr. 14, 2008, 8 pages.
Interview Summary for U.S. Appl. No. 11/267,063, mailed on Aug. 6, 2008, 4 pages.
Amendment in Response to Non-Final Office Action for U.S. Appl. No. 11/267,063, filed Sep. 8, 2008, 8 pages.
Notice of Allowance for U.S. Appl. No. 11/267,063, mailed on Dec. 30, 2008, 7 pages.
U.S. Appl. No. 11/788,590, filed on Apr. 19, 2007 [Von Nussbaum et al.].
Restriction Requirement for U.S. Appl. No. 11/788,590, mailed on Oct. 30, 2008, 10 pages.
Response to Restriction Requirement for U.S. Appl. No. 11/788,590, filed on Dec. 29, 2008, 5 pages.
Non-Final Office Action for U.S. Appl. No. 11/788,590, mailed on Mar. 30, 2009, 19 pages.
Amendment in Response to Non-Final Office Action for U.S. Appl. No. 11/788,590, filed on Jun. 23, 2009, 17 pages.
U.S. Appl. No. 11/788,649, filed on Apr. 20, 2007 [Von Nussbaum et al.].
Restriction Requirement for U.S. Appl. No. 11/788,649, mailed on Jul. 24, 2008, 10 pages.
Response to Restri
Anlauf Sonja
Beck Hartmut
Brunner Nina
Cancho-Grande Yolanda
Endermann Rainer
Aicuris GmbH & Co. KG
Morrison & Foerster / LLP
Russel Jeffrey E
LandOfFree
Lysobactin amides does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Lysobactin amides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Lysobactin amides will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4270193